1. Test an "earnings bubble" claim with the direction of estimate revisions, not the level (2:42)
The repeatable method
- Strip out the non-repeatable items first (investment gains, mark-ups of private stakes) so you are arguing about the operating number.
- Then measure the thing sceptics can't wave away: how analysts have changed estimates during the quarter, benchmarked against a long history. Analysts normally cut mid-quarter to lower the hurdle; if they are raising, they are being forced to by management guidance.
- Cross-check earnings quality with revenue breadth — how many sectors are growing sales. "You can fake earnings, you can't fake revenue."
- Notice when the bear case has mutated (from "multiple expansion, too narrow" to "earnings bubble"). A thesis that changes shape while staying negative is a sentiment position, not an analysis.
Here: Brown — Q2 growth ~50%, or 31% stripping out GOOGL and AMZN investment gains; next quarter 28.8% on the same basis. The killer stat: "in the last 80 quarters — 20 years of data — the average change in estimates for the first month of the quarter has been −1.9%. Right now it's +0.1%." And "all 11 sectors are reporting year-over-year sales growth… plus 14% in the quarter."
Watch for
- In-quarter estimate revisions turning negative again (the first crack); sales growth narrowing to fewer sectors; a bear thesis that keeps changing its reason.
2. Audit demand for pull-forward before extrapolating a supplier's best year ever (6:55)
The repeatable method
- When end-customers are spending heavily, ask when the spending was decided, not just how big it is.
- Look for the pull-forward tell: buyers accelerating next year's purchases into this year to lock in today's prices — "the known known versus the unknown unknown of next year's prices."
- Trace the order book down the chain to the 2nd- and 3rd-order suppliers, who see the pull-forward last and therefore feel the air pocket last.
- Convert it into a date, not a verdict: the thesis is intact "probably through the end of this year," which tells you the holding period rather than whether to own it.
Here: Ethridge — the four hyperscalers "pre-funded a lot of their purchases for next year this year… they'd rather pay today's elevated price versus next year's." So for third-order names like CAT ("having its best year probably ever") and GLW, "how much of that spending that has reached them already is going to slow down because the companies accelerated this year and they won't do it again next year?"
Watch for
- Customers describing purchases as pre-buys or price locks; supplier backlogs that front-load one year; the second derivative of orders rather than the level.
3. Separate AI suppliers from AI adopters — and buy margin, not revenue (5:51)
The repeatable method
- Ask the deflating question of any "AI stock": is this company selling AI, or using it?
- For adopters, look for businesses with large, repetitive, people-heavy processes (claims, underwriting, servicing) where automation drops straight to operating margin.
- Verify with the margin line rather than a revenue line — there will never be an "AI revenue" disclosure, so the evidence is expanding operating margins on flat-ish sales.
- Treat this as the durable half of the theme: adopters aren't exposed to the capex cycle that eventually catches the suppliers.
Here: Brown — "Is ALL and is MET selling GPUs? … I really believe the story of insurance companies as an example of companies that are using AI, turning it on their businesses, weaponizing it against the problems that they once had and using it to get more efficient. So their operating margins are getting far better." Later: TRV, CB, ALL, MET — "all of those charts look great" — and the same logic under BRK.B: "you don't have to invest directly in AI to have benefited from AI."
Watch for
- Operating-margin expansion without revenue acceleration; management describing headcount or process savings; a sector with high fixed manual workload.
4. The Jenga test — apply one bear case consistently across the whole ecosystem (19:11)
The repeatable method
- State the bear case precisely (here: vendor financing manufactures revenue, the Cisco-1999 pattern).
- Now apply it to every name that depends on the same demand. If the accusation is true, the companies you still like are also impaired.
- If you cannot hold the bear case and the bull positions simultaneously, one of them is wrong — "you can't pick and choose which aspects of the overall AI trade… it's like pulling the wrong Jenga piece out."
- Then ask the counterfactual from the accused company's seat: what is the alternative? If not financing customers, the business goes to a competitor's chips.
- Check it can afford the strategy from cash rather than leverage.
Here: NVDA and the circular-financing charge. Brown: "if you question that, you have to question the entire thing. Do we still feel really great about SKHY and Samsung, or do we not? If you believe in one, you have to believe in the other." The counterfactual: ten neoclouds without their own cash flow are borrowing (from BX and others) — "if you're Jensen, do you want NVIDIA chips in there, or Trainium chips?" The affordability check: "$48.5 billion in free cash flow… they still have the ability to lend out dollars in the form of structured loans."
Watch for
- A bear case you apply selectively; customers who cannot self-fund; whether the vendor finances from free cash flow or from debt.
5. Price a lock-up as a supply-versus-forced-demand equation (21:07)
The repeatable method
- Quantify the supply precisely: shares becoming tradeable, the resulting free float percentage, and the calendar of remaining tranches.
- Quantify the offsetting forced demand: index float adjustments mechanically raise the weight as the float grows, forcing index funds to buy — find the exact adjustment date.
- Ask whether the original float was artificially small. A tiny float plus instant index inclusion means the pre-unlock price was never a real clearing price; the unlock is price discovery.
- Check the cash-burn clock separately: money raised versus money spent per quarter tells you whether more supply (a capital raise) is coming behind the unlock.
- Set your bid on valuation, and require yourself to say why a lower price would be acceptable — otherwise you are price-insensitive and buying the story.
Here: SpaceX — available shares +140% to over 1.5bn (from 629m), 50% free float by January (Bernstein), against a Nasdaq-100 float adjustment in early September that "could mean more forced buying." Brown: $86B raised, "already spent like a fifth of it in a quarter, so they're going to need to raise capital again," and "if you didn't like it with only 5% of the shares available to trade, you're going to love it at 12%." Ethridge: "I'd love to buy it under 100 — depending on why it's under 100." Brown's needle at buyers naming 115 then 109: "if we're totally insensitive to price… this is about the emotional need to belong to the story."
Watch for
- The remaining unlock calendar; index rebalance dates; cash burned per quarter versus cash raised; your own willingness to name a price and a reason.
6. Kill a thesis when a new, structural cost line appears — not when growth slows (28:29)
The repeatable method
- Write down the one thing keeping you in the position (here: pricing power proved by raising prices without losing subscribers).
- Separate cyclical cost pressure from structural: marketing spend to win the next customer is a concern; a permanent new function the company must staff is a thesis break.
- Ask whether the new cost gets better or worse with time. If the driver (cheap generative AI) is getting cheaper and more abundant, the cost compounds.
- Close with relative value: an expensive multiple is only intolerable when a comparable business in the same space is available cheaper.
Here: Ethridge sells SPOT — held for pricing power, sold when opex rose both for customer acquisition and "because AI slop on the platform has gotten so out of control… how much time and how many tools they've had to create in order to manage that. And I think it only gets worse from here." The relative-value close: 34× forward "when you could own something like NFLX that's trading below the market at this point, and they kind of operate in the same space."
Watch for
- New permanent cost centres disclosed on the call (moderation, compliance, security); a cost driver that scales with an accelerating outside trend; a cheaper same-space comparable.
7. Buy a washed-out name on confirmation, and pay for the worse price with smaller size (16:53)
The repeatable method
- Identify the quality name inside the wreckage (a 30–40% single-month drawdown in a group, not a broken business).
- Do not buy the first green day. Name the specific overnight/offshore market that must confirm (here, Korea) and wait for follow-through.
- Accept that confirmation costs you the first leg — then halve the size rather than abandoning the trade or paying up in full.
- Anchor the thesis on a structural role in the build-out you can describe in one sentence, so the position survives the next drawdown.
Here: Baruch on MRVL, down 37% in July: "we didn't want to really buy the name just yet… let's see how South Korea goes overnight and see if there's follow-through. Of course Marvell was up 14% on Tuesday. So we still bought it — we bought half as much as we were hoping for, which is a 1% add." The one-sentence role: "the connectivity backbone with AI custom silicon, optical networking and AI memory solutions… CXL allows hyperscalers to pool memory outside of processors."
Watch for
- The overseas market that leads your name; a follow-through session rather than a single bounce; whether you would still buy at a 14% worse price (if not, it wasn't conviction).
8. Find the one belief the whole valuation hinges on — then track its evidence, not the earnings (33:26)
The repeatable method
- Notice when a stock falls after good reports repeatedly (six of the last seven). That pattern means earnings are not the variable.
- Identify the single disbelief doing the work, and quantify it: what multiple is the market paying now, and what would it pay if the belief flipped?
- List the concrete, non-earnings developments that would change the belief — partnerships, supply, and above all financing for the new business model.
- Do the unit economics of the new model yourself so you know it's real (rides per asset per day, the cost removed).
- Accept that you can't time it: "this stock could be re-rated overnight. I just can't tell you when" — which is a sizing instruction.
Here: UBER — "down 6 out of the last 7 quarters after reporting. Doesn't matter if they beat, if they miss." The single belief: nobody thinks Uber's AV coalition competes with Waymo and Cybercab — "that's why the stock trades at 15 times forward earnings… if anybody believed, the stock would be $120." The evidence to track: launching with NVDA, ten more AV-ready OEMs, and PE/private-credit buying AV fleets onto the app — "the average AV on the app right now is 15 or 20 rides a day. We take out the most expensive part, the human driver who has a take rate of 20–30%."
Watch for
- Repeated post-earnings declines on good numbers; a nameable single disbelief; third-party capital actually funding the new model (the tell that it's real).
9. A "best stock" is not permanently a buy — pre-set the retest level that ends the trade (37:12)
The repeatable method
- Record the breakout level that got you in. That level is now the trade's referee.
- On a pullback, distinguish a normal retest from a failure — and set the failure condition in advance as a closing price on a specific date (a weekly close, not an intraday wick).
- Pair the technical trigger with a fundamental reason for suspicion (here, costs rising after a 40% headcount cut), so you are not exiting on noise alone.
- Say it publicly and close the loop: "not every time we talk about a best stock is it a buy."
Here: XYZ (Block) — flagged at 76, ran to 86, now retesting the 81 breakout after a decent quarter with rising expenses despite a ~40% headcount cut: "this is what I mean by nobody really trusts Jack Dorsey for long… I would be very careful remaining long this trade. A close to end the week below 80, I would be just taking this one off the table."
Watch for
- The original breakout level being retested; a weekly close below it; costs moving the wrong way against a restructuring story.
10. The "own it forever" test — is the business designed out by the next technology? (39:17)
The repeatable method
- Find the business that sits in the middle of a transaction that must happen regardless of the economy, and count the transactions.
- Ask the disruption question directly: could AI (or the next platform) remove this company from the flow? If the answer is no, the multiple can be paid.
- Check that it is investing in the replacement technology too — patent positions in the successor rail are how an incumbent avoids being designed out.
- Combine with a technical entry: an old high never revisited means no trapped sellers overhead once it clears.
- Conclude with a holding rule, not a target: own it rather than trading in and out.
Here: V (and MA) — Brown: up 3,250% since IPO, revenue and earnings both +11%, a golden cross, and the May-2025 high at 375 unvisited "so there really are no natural sellers here. The path to 400 is clear and wide open." Ethridge: ~300 billion transactions a year, "literally in everybody's pocket the same way the iPhone is," third-largest holder of blockchain patents behind BAC and Mastercard — "they'll continue to be sitting right between every single swipe transaction forever."
Watch for
- Transaction volume growth; patent/standards position in the successor technology; an old high with no overhead supply; the temptation to trade a compounder.
11. Label a speculation as a speculation — and require it to have bought real revenue (31:12)
The repeatable method
- In a pre-commercial industry, concentrate into the single name most likely to reach service first rather than owning the category.
- Require an existing cash-generating business inside the story — revenue that funds the capex is what separates a spec from a story.
- Check for a strategic partner with equity at risk, not just a memorandum.
- Find the first real-world launch market and date, so the thesis has a checkpoint.
- State the disqualifier out loud: no earnings, no dividends, for a long time. That sentence sets the position size.
Here: JOBY — Ethridge sold ACHR and consolidated: "I think this will be the first one to truly commercialize eVTOLs." The revenue leg: Blade, acquired last year, "brought in $120 million-plus annual revenue, and revenue becomes really important when you're funding massive CapEx." Toyota (TM) has a JV and an equity stake; service expected in Dubai and Abu Dhabi by year end. The label: "if you need earnings and dividends, you ain't going to see either one for a very long time. But as a spec, this is one of my favorite plays."
Watch for
- An acquired revenue base funding development; a partner with equity in; a dated first-market launch; whether you can say the word "speculation" about your own position.
12. Judge a deleveraging event by what didn't break (15:20)
The repeatable method
- When a speculative pocket unwinds, catalogue the casualties precisely — leveraged single-stock ETFs, specific options trades, individual funds.
- Then ask the only question that matters for the index: did the system buckle, or did the trash get taken out?
- Look at where the money went rather than assuming it left — money rotating into another sector is a health signal, money leaving entirely is not.
- Inspect the blown-up book's other side: a fund long the fever and short the hated group means the squeeze is a two-way event, which is why the recovery was so violent.
Here: Brown — "a healthy bull market takes out its own trash. We saw a momentary speculative fever… predominantly memory chip makers, a lot of it in Korea, and people paid for it. Those 2× leveraged single-stock ETFs got wiped out… one notable hedge fund [with] the biggest trading loss at a hedge fund ever in dollar terms. But the entire system didn't buckle." The other side of that book: it "was not only long memory, it was short software, and those shorts went against [them]" — IGV having been 37% off its highs in April. Baruch: healthcare +20% off the low over two months, "the money [went] elsewhere."
Watch for
- Losses contained to levered vehicles and single funds; sector rotation rather than net outflow; a crowded short on the other side of the blow-up (the squeeze fuel).
Methods distilled from the public CNBC Halftime Report audio episode (transcript in transcript.txt) for personal study. Not investment advice. © CNBC for source material.